<DOC>
	<DOCNO>NCT00396994</DOCNO>
	<brief_summary>The purpose study determine daily low magnitude , high frequency whole body vibration improve bone density senior .</brief_summary>
	<brief_title>`` VIBES '' -- Low Magnitude Mechanical Stimulation Improve Bone Mineral Density</brief_title>
	<detailed_description>The treatment option osteoporosis , major health complication age population , limited pharmacologic intervention , majority antiresorptive . Preliminary data demonstrate high frequency , low magnitude mechanical stimulation ( LMMS ) preserve bone mineral density ( BMD ) prevent bone resorption due disuse age , stimulate new bone formation . To confirm extend observation , study three-year , double-blind , randomize , placebo-controlled clinical trial LMMS 200 elderly woman men ( 60 year age old ) . A clinical center locate Boston , MA recruit participant multiple independent living facility close geographic proximity . Participants meet inclusion/exclusion criterion randomize either brief daily exposure LMMS vibrate platform placebo platform three year period . All participant receive 1000 mg elemental calcium 800 IU vitamin D per day . This study provide new important information role low magnitude high frequency mechanical stimulation skeleton .</detailed_description>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<criteria>Men woman 60 year ethnic group Weight le 250 pound Absence terminal cancer illness necessitate hospice level service Capable follow protocol understand provide informed consent Scoring le 12 Short Blessed Test Immobilization axial low appendicular skeleton within last year Nonambulatory ( ambulation assistive device permit ) Malignancy cure thyroid cancer skin cancer Hip replacement internal fixation , total knee replacement , low limb fracture within past year , bilateral hip replacement Medications : glucocorticoid , suppressive dos thyroid hormone determine screen TSH , anticonvulsant drug ( phenytoin , phenobarbital , carbamazepine ) , estrogen/testosterone replacement , selective estrogen receptor modulators ( SERMs ) , PTH , bisphosphonates 1 month past year , calcitonin therapy within precede month , fluoride therapy time Paget 's disease bone , rheumatoid arthritis connective tissue disorder require systemic treatment disease modify drug , history Cushing 's syndrome Fragility fracture within past five year unless pharmacologic therapy prescribe</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>biomechanics</keyword>
	<keyword>osteogenesis</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>bone regeneration</keyword>
</DOC>